Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers.
about
Curcumin AntiCancer Studies in Pancreatic CancerPhase I dose-escalation trial of intravaginal curcumin in women for cervical dysplasia.Curcumin: An age-old anti-inflammatory and anti-neoplastic agent.Therapeutic applications of curcumin for patients with pancreatic cancer.Curcumin: a potential candidate in prevention of cancer via modulation of molecular pathways.The multifaceted role of curcumin in cancer prevention and treatment.Curcumin Modulates Pancreatic Adenocarcinoma Cell-Derived Exosomal Function.Attenuation of indirect markers of eccentric exercise-induced muscle damage by curcuminBeyond Yellow Curry: Assessing Commercial Curcumin Absorption TechnologiesNovel Functionalized Selenium Nanoparticles for Enhanced Anti-Hepatocarcinoma Activity In vitro.Complementary and alternative medicines in prostate cancer: from bench to bedside?Effects and synergy of feed ingredients on canine neoplastic cell proliferationTherapeutic Applications of Curcumin NanoformulationsImprovement of Oral Bioavailability of Curcumin upon Microencapsulation with Methacrylic Copolymers.Effects of curcumin in pediatric epithelial liver tumors: inhibition of tumor growth and alpha-fetoprotein in vitro and in vivo involving the NFkappaB- and the beta-catenin pathways.Curcumin nanomedicine: a road to cancer therapeuticsNano-curcumin inhibits proliferation of esophageal adenocarcinoma cells and enhances the T cell mediated immune response.Hesperidin Induces Apoptosis by Inhibiting Sp1 and Its Regulatory Protein in MSTO-211H CellsNovel curcumin-loaded magnetic nanoparticles for pancreatic cancer treatmentErbB Proteins as Molecular Target of Dietary Phytochemicals in Malignant Diseases.Oxidative Stress: A New Target for Pancreatic Cancer Prognosis and Treatment.Curcumin nanoformulations: a future nanomedicine for cancer.Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin.Curcumin and liver disease.Curcumin, inflammation, and chronic diseases: how are they linked?The challenges for cancer chemoprevention.Curcumin Nanotechnologies and Its Anticancer Activity.High bioavailability curcumin: an anti-inflammatory and neurosupportive bioactive nutrient for neurodegenerative diseases characterized by chronic neuroinflammation.Curcumin induces autophagy in ACC-MESO-1 cells.Development of a validated UPLC-qTOF-MS Method for the determination of curcuminoids and their pharmacokinetic study in mice.A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin) in cancer patients.Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol.A Comparative Pharmacokinetic Assessment of a Novel Highly Bioavailable Curcumin Formulation with 95% Curcumin: A Randomized, Double-Blind, Crossover Study.Randomized Pharmacokinetic Crossover Study Comparing 2 Curcumin Preparations in Plasma and Rectal Tissue of Healthy Human Volunteers.The synergistic effects of ω-3 fatty acids and nano-curcumin supplementation on tumor necrosis factor (TNF)-α gene expression and serum level in migraine patients.Antihepatoma activity of Artocarpus communis is higher in fractions with high artocarpin content.Protective and Restorative Effects of Nutrients and Phytochemicals.Local administration of curcumin-loaded nanoparticles effectively inhibits inflammation and bone resorption associated with experimental periodontal disease.Evidence-based complementary treatment of pancreatic cancer: a review of adjunct therapies including paricalcitol, hydroxychloroquine, intravenous vitamin C, statins, metformin, curcumin, and aspirinCurcumin, Cardiometabolic Health and Dementia
P2860
Q26738714-96195966-C48C-4374-91D7-393D97F73333Q33764245-C9D33820-1719-4A4B-A12B-BDBB502DB268Q33896515-20D74E66-7A7C-4990-981F-048F136875F1Q33948351-770D3601-0869-4C13-A214-C1D89BC159F8Q34252516-F72CCF3C-2B6D-4C2D-904C-A77BA8651A4AQ34667865-A4C7DDF8-8579-4614-AD83-5E27FED86205Q35692600-5D2E599B-5389-4AA2-AD5D-A104D4CAC0D1Q35952640-7600E50D-2862-4339-BDAB-1231A6224F1BQ35955023-8728A4B7-1F88-4725-8693-8BFA8F148D81Q36023716-99F6D9EE-85B8-457D-86B3-66EB6C836A93Q36051522-46280DA7-CF68-4357-8AE3-64EE4076B6BEQ36092970-3C053CA3-BA7C-4514-9ABF-882CE951687CQ36232513-B101137A-357D-4703-B5DE-735A9BCD4DF7Q36244041-FDC904DF-F4F9-45EC-8104-5B07B965953AQ36562132-E1236ED0-6615-47E7-A566-7B3ED31F7D11Q36807261-38416F43-916D-4F66-932E-FF4B46E5B506Q36881910-F3A5A7DC-9084-4DB5-AEBA-C08EF9D30912Q37224560-73EC20EE-0687-4391-B2E5-9AB69FC19943Q37662418-DF403868-8822-43DF-A5BF-D6DD93ED55C8Q37668848-D801B50E-A0BF-4D4F-9FC2-4AC8C93BED09Q37729938-F4D477A9-2C9B-41BA-8E0B-610A39F83F46Q37940793-B915227D-BA24-4C6D-91CC-B30269E670E1Q38042744-ADE300A1-CD81-495A-9B2F-0623580B9017Q38072883-4EAF5797-440F-4BBA-8ADA-4CA021B3A760Q38501499-BF0DEDD2-4FCD-4F02-A3A9-310A4904880AQ38643625-F63339E7-E511-4D00-A256-11CEEA7771E0Q38746695-8FD622E2-BA95-40CE-BD1E-BABF78CAB841Q39138022-B22FE44C-EEFB-4ED1-89FE-2E1EE3FD3A01Q39385991-C5040505-DA19-4BC6-B9E7-A9D9AC918C02Q41048948-9ACC7C1C-9CF5-4CCA-88C8-DEA9A2003A30Q44600268-A0849661-F3B5-4970-9C07-EC6B3BA250B1Q47191893-2A5C0539-3A7A-4D4F-9E33-D42789354945Q47770834-A50E8440-8251-4B1F-8C4E-6B1513E3EBCFQ49184030-DDCC521D-EDA9-4270-8705-7432D1F24DA6Q50668061-9DA58C69-E4CD-453B-869B-883373EB9427Q51418002-17BFE405-B356-4CA1-85BC-656A4614BB77Q53821180-75595BD8-A1E4-493C-8645-368E56C4445CQ54963833-AB4F23D5-DDA2-4E50-98CD-7D44513196AFQ57176118-9E044D28-4F2F-4EA4-A1B8-20F8355702F4Q58699640-E0936388-124A-4ABB-BF0F-6F839981A22E
P2860
Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Dose-escalation and pharmacoki ...... , in healthy human volunteers.
@ast
Dose-escalation and pharmacoki ...... , in healthy human volunteers.
@en
Dose-escalation and pharmacoki ...... , in healthy human volunteers.
@nl
type
label
Dose-escalation and pharmacoki ...... , in healthy human volunteers.
@ast
Dose-escalation and pharmacoki ...... , in healthy human volunteers.
@en
Dose-escalation and pharmacoki ...... , in healthy human volunteers.
@nl
prefLabel
Dose-escalation and pharmacoki ...... , in healthy human volunteers.
@ast
Dose-escalation and pharmacoki ...... , in healthy human volunteers.
@en
Dose-escalation and pharmacoki ...... , in healthy human volunteers.
@nl
P2093
P2860
P1476
Dose-escalation and pharmacoki ...... , in healthy human volunteers.
@en
P2093
Atsushi Imaizumi
Hiroki Sasaki
Hiroshi Ishiguro
Kazu Tsujiko
Masashi Kanai
Momo Hashiguchi
Shigemi Matsumoto
Tsutomu Chiba
Yoshihiko Otsuka
P2860
P2888
P356
10.1007/S00280-011-1673-1
P577
2011-05-21T00:00:00Z
P5875
P6179
1021384108